[go: up one dir, main page]

DK0694166T3 - Detection of CNS disease - Google Patents

Detection of CNS disease

Info

Publication number
DK0694166T3
DK0694166T3 DK94912596T DK94912596T DK0694166T3 DK 0694166 T3 DK0694166 T3 DK 0694166T3 DK 94912596 T DK94912596 T DK 94912596T DK 94912596 T DK94912596 T DK 94912596T DK 0694166 T3 DK0694166 T3 DK 0694166T3
Authority
DK
Denmark
Prior art keywords
pct
detection
sec
disease
date
Prior art date
Application number
DK94912596T
Other languages
Danish (da)
Inventor
Roy Jackman
Sally Jane Everest
Original Assignee
Mini Agriculture & Fisheries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mini Agriculture & Fisheries filed Critical Mini Agriculture & Fisheries
Application granted granted Critical
Publication of DK0694166T3 publication Critical patent/DK0694166T3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/493—Physical analysis of biological material of liquid biological material urine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]
    • Y10T436/148888—Uric acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analyzing Materials By The Use Of Fluid Adsorption Or Reactions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PCT No. PCT/GB94/00766 Sec. 371 Date Dec. 1, 1995 Sec. 102(e) Date Dec. 1, 1995 PCT Filed Apr. 12, 1994 PCT Pub. No. WO92/24554 PCT Pub. Date Oct. 27, 1994Techniques for the detection of disease of the central nervous system, particularly of bovine spongiform encephalopathy or "mad cow disease", scrapie and related states, are provided based upon the detection of a factor present in the urine of affected animals or humans. That factor is defined in terms of elution data from an ion exchange column and by electrochemical characteristics.
DK94912596T 1993-04-13 1994-04-12 Detection of CNS disease DK0694166T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939307523A GB9307523D0 (en) 1993-04-13 1993-04-13 Detection of cns gases
PCT/GB1994/000766 WO1994024554A1 (en) 1993-04-13 1994-04-12 Detection of cns disease

Publications (1)

Publication Number Publication Date
DK0694166T3 true DK0694166T3 (en) 1999-11-22

Family

ID=10733679

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94912596T DK0694166T3 (en) 1993-04-13 1994-04-12 Detection of CNS disease

Country Status (10)

Country Link
US (1) US5807687A (en)
EP (1) EP0694166B1 (en)
AT (1) ATE181770T1 (en)
AU (1) AU6507394A (en)
DE (1) DE69419313T2 (en)
DK (1) DK0694166T3 (en)
ES (1) ES2135571T3 (en)
GB (2) GB9307523D0 (en)
GR (1) GR3030672T3 (en)
WO (1) WO1994024554A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU731770B2 (en) 1996-03-15 2001-04-05 Imedex Process for removing unconventional transmissible agents from a protein solution
FR2746030B1 (en) * 1996-03-15 1998-04-17 METHOD FOR ELIMINATING NON-CONVENTIONAL TRANSMISSION AGENTS (NCTAs) FROM AN ALBUMIN SOLUTION
FR2750887B1 (en) * 1996-07-09 1998-10-23 Imedex METHOD FOR ELIMINATING NON-CONVENTIONAL TRANSMISSIBLE AGENTS (NCTAs) FROM A PROTEIN SOLUTION
DE69731194T2 (en) * 1996-04-17 2005-10-20 The Victoria University Of Manchester ANALYSIS TO DETECT DEGENERATIVE BRAIN DISEASES
CA2206774A1 (en) * 1997-06-16 1998-12-16 Rick E. Preddie "prionins", highly specific markers for noninvasive presymptomatic defection of tse diseases, and targets for therapeutic reagents to prevent and control tse diseases in animals and humans
IL141950A0 (en) * 2000-10-22 2002-03-10 Hadasit Med Res Service Diagnosis of prion diseases
DE10127500A1 (en) * 2001-06-06 2002-12-12 Simon Kammermeier Early recognition of bovine spongiform encephalopathy for living cattle involves stimulus of the brains with an external stimulus and measurement and evaluation of the resulting brain activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990007712A1 (en) * 1988-12-23 1990-07-12 Bissendorf Peptide Gmbh Antigen associated with degenerative diseases of the central nervous system (cns), antibody which reacts with said antigen and method for diagnosing dysfunctions of the cns

Also Published As

Publication number Publication date
ATE181770T1 (en) 1999-07-15
AU6507394A (en) 1994-11-08
GB9307523D0 (en) 1993-06-02
DE69419313T2 (en) 1999-11-11
GB9520345D0 (en) 1995-12-06
WO1994024554A1 (en) 1994-10-27
ES2135571T3 (en) 1999-11-01
DE69419313D1 (en) 1999-08-05
US5807687A (en) 1998-09-15
GR3030672T3 (en) 1999-11-30
EP0694166B1 (en) 1999-06-30
GB2291968A (en) 1996-02-07
GB2291968B (en) 1997-08-13
EP0694166A1 (en) 1996-01-31

Similar Documents

Publication Publication Date Title
Fuster Cognitive functions of the frontal lobes.
DE69021418D1 (en) Polarizing beam splitter and system for image projection through light valves.
EP0847556A4 (en) SYSTEM FOR CONSULTING AND DISSEMINATING ONLINE / INFORMATION SERVICES
DE60140130D1 (en) METHOD AND DEVICE FOR CENTRALIZED SNOOP FILTERING
NO972043D0 (en) Tienopyridine or thienopyrimidine derivatives and their use
DK0694166T3 (en) Detection of CNS disease
DE69217005D1 (en) Imaging process, developer and imaging system
TR199501668A2 (en) Improved diaper fixing language.
FR2702061B1 (en) Information processing device.
NL194929B (en) Projection exposure system.
NL194951B (en) Projection exposure system.
DE59607114D1 (en) Finishing agent
FR2690832B1 (en) METHOD FOR IDENTIFYING THE REAL POSITIONING OF THE CENTER OF AN EYE PUPIL.
DK0745072T3 (en) 4-amino derivatives of 5-substituted mycophenolic acid
ATE177952T1 (en) SYNTHESIS OF IOVERSOL USING CHLORACETYLCHLORIDE
BR9708511A (en) Use of compounds use of 6- [3- (1-adamantyl) -4-methoxyphenyl] -2-naphthoic acid and use of 6- [3- (1-adamantyl) -4-hydroxyphenyl] -2-naphthoic acid
FR2731235B1 (en) ELECTRO-OXIDATION PROCESS FOR PHOTOGRAPHIC SOLUTIONS
EP0643382A3 (en) Magnetic recording system.
FR2733330B1 (en) ELECTRO-OXIDATION PROCESS FOR PHOTOGRAPHIC SOLUTIONS
BR7201834U (en) Horseshoe provision introduced for horses' hoof.
FR2708819B1 (en) Information exchange system by server center.
EP0651800A4 (en) Basophil granule proteins.
BR7301990U (en) Horseshoe introduced for horses
ES1026265Y (en) PERFECTED REGULATOR FOR MILKING FACILITIES.
ES2148753T3 (en) METHYLPYROLIDINYLINDOL SALT.